We observed an increase of CD8+/GATA3+ lymphocytes of gastric cancers compared to non-neoplastic mucosa in non-CVID patients along with a lack of significant difference in immune cell counts in CVID-patients. This evidence concerns the gene GATA3 and gastric cancer.